In Phase 3 TRIUMPH-1, the 12 mg arm produced mean body weight reduction of 28.3% at 80 weeks
B., Yang, D., Peng, H., Colbourne, K., & Brown, T
Warning signs requiring urgent evaluation include persistent vomiting that prevents fluid intake, severe upper abdominal pain (particularly if radiating to the back), signs of hypoglycemia that don't resolve with carbohydrate intake, symptoms of dehydration (decreased urination, extreme thirst, dizziness), or any other concerning reactions
Incorporating stress-management techniques can be instrumental in maintaining these levels and preventing deficiencies
Studies suggest that GLP-1-mediated weight loss may lower inflammatory markers including C-reactive protein and TNF-alpha, which contribute to osteoarthritis progression
Many people achieve excellent weight loss at lower maintenance doses like 1.0 to 1.7 mg and experience fewer side effects